Saketh Guntupalli, MD

Professor, OB-GYN-Gynecologic Oncology


FacultyPhoto
Medical School
  • MD, University of Texas Medical School at Houston (2005)
Undergraduate School
  • BA, Johns Hopkins University (MD) (2001)
Residency
  • Baylor College of Medicine Program, Obstetrics and Gynecology (2009)
Fellowships
  • Washington University/Barnes-Jewish Hospital/St. Louis Children's Hospital, Gynecologic Oncology (2012)
Languages
English, Spanish, German, French, Hindi, Telugu
Department
OB-GYN-Gynecologic Oncology

Professional Titles

  • Director-Division of Gynecologic Oncology
  • Karen M. Jennison Endowed Chair in Gynecologic Oncology

Recognitions

  • Resident of the Year- Department of Obstetrics and Gynecology- Chief Year, Baylor College of Medicine (2009)

Research Interests

All gynecologic cancer conditions.

Publications

  • Matei DE, Enserro DM, Randall ME, Mutch D, Small W, DiSilvestro PA, Spirtos NM, O'Malley DM, Cantuaria GH, Michelin D, Waggoner S, Shahin M, Guntupalli S, Lara O, Ueland FR, Warshal D, Bonebrake A, Tewari KS, Tan A, Powell MA, Walker JL, Santin AD, Kim JH, Miller DS. Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma. J Clin Oncol. 2024 Dec 19;:JCO2401121. [Epub ahead of print] PubMed PMID: 39700442
  • Nguyen LL, Watson ZL, Ortega R, Woodruff ER, Jordan KR, Iwanaga R, Yamamoto TM, Bailey CA, To F, Lin S, Villagomez FR, Jeong AD, Guntupalli SR, Behbakht K, Gibaja V, Arnoult N, Chuong EB, Bitler BG. EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner. Mol Cancer Res. 2024 Dec 3;22(12):1117-1127. PubMed PMID: 39136655
  • Nguyen LL, Watson ZL, Ortega R, Woodruff ER, Jordan KR, Iwanaga R, Yamamoto TM, Bailey CA, To F, Jeong AD, Guntupalli SR, Behbakht K, Gibaja V, Arnoult N, Cocozaki A, Chuong EB, Bitler BG. Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation. Mol Cancer Ther. 2024 Jun 12;:OF1-OF16. [Epub ahead of print] PubMed PMID: 38863225
  • Floyd J, Porragas-Paseiro H, Nguyen C, Moroney MR, Mastroyannis S, Guntupalli SR. Validation of the Safety and Efficacy of Apixaban as Postoperative Thromboembolism Prophylaxis for Patients with Gynecologic Malignancies. Ann Surg Oncol. 2024 Aug;31(8):5102-5110. PubMed PMID: 38780692
  • Li Y, Ettah U, Jacques S, Gaikwad H, Monte A, Dylla L, Guntupalli S, Moghimi SM, Simberg D. Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin. Mol Pharm. 2024 Jun 3;21(6):3053-3060. PubMed PMID: 38743264

Professional Memberships

  • American Association of Physicians of Indian Origin (AAPI) - Medical Students, Residents and Fellows Section, President Elect June 2006 - May 2007
  • Governmental Affairs Committee, Society of Gynecologic Oncologists (SGO), Member
  • American Congress of Obstetrics and Gynecology, Member
  • Society of Gynecologic Oncologists, Candidate Member
  • American College of Surgeons, Member

Practice Locations

University of Colorado Cancer Center - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

Hospital Affiliation
  • University of Colorado Hospital
  • Denver Health Medical Center
  • UCHealth Highlands Ranch Hospital

Center Affiliations

Specialty Information

Specialties
  • Gynecologic Oncology, Board Certification
Conditions & Treatments
  • Cancers - Cervical Cancer
  • Cancers - Chemotherapy
  • Cancers - Gynecologic Cancer
  • Cancers - Ovarian Cancer
  • Cancers - Uterine Cancer
  • Surgery - Robotic Surgery
  • Women's Health - Endometriosis
  • Cancers
  • Women's Health
  • Surgery
Clinical Interests
I am trained to treat women with gynecologic cancers and pre-cancers. I have a special interest in minimally invasive surgical techniques including laparoscopy and Da Vinci assisted Robotic surgery.

Care Philosophy
I have been treating patients with gynecologic cancers for 15 years and feel incredibly honored to do so. I believe in a patient-centered view of care for women with cancer and pre-cancers. We work together as a team and decide on a plan of care which conforms to the social and cultural needs of the many different patients that come into our practice. I firmly believe that patients should be given clear and prompt information about their conditions and believe that the most important part of this is an open line of communication.

Personal Interests
My personal interests include tennis, basketball, foreign travel and national politics.

Public Speaking
Yes